Brugada Syndrome 6
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Genetics of Brugada syndrome.
|
27761167 |
2016 |
Brugada Syndrome 6
|
0.600 |
GeneticVariation
|
disease |
CLINVAR |
KCNE3 T4A as the genetic basis of Brugada-pattern electrocardiogram.
|
22987075 |
2012 |
Brugada Syndrome 6
|
0.600 |
GeneticVariation
|
disease |
CLINVAR |
Novel KCNE3 mutation reduces repolarizing potassium current and associated with long QT syndrome.
|
19306396 |
2009 |
Brugada Syndrome 6
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Short QT syndrome.
|
16301704 |
2005 |
Brugada Syndrome 6
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Brugada Syndrome 6
|
0.600 |
Biomarker
|
disease |
CTD_human |
|
|
|
Brugada Syndrome (disorder)
|
0.510 |
Biomarker
|
disease |
CLINGEN |
Forty consecutive patients with Brugada-pattern electrocardiogram (ECG) underwent comprehensive genetic analysis of BrS-causing genes including SCN5A, SCN1B, SCN3B, CACNA1C, CACNB2, KCNE3 and KCNE5.
|
22987075 |
2012 |
Brugada Syndrome (disorder)
|
0.510 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Novel KCNE3 mutation reduces repolarizing potassium current and associated with long QT syndrome.
|
19306396 |
2009 |
Brugada Syndrome (disorder)
|
0.510 |
Biomarker
|
disease |
CLINGEN |
These results provide definitive evidence for a functional role of KCNE3 in the modulation of I(to) in the human heart and suggest that mutations in KCNE3 can underlie the development of BrS.
|
19122847 |
2008 |
Brugada Syndrome (disorder)
|
0.510 |
GeneticVariation
|
disease |
BEFREE |
These results provide definitive evidence for a functional role of KCNE3 in the modulation of I(to) in the human heart and suggest that mutations in KCNE3 can underlie the development of BrS.
|
19122847 |
2008 |
Brugada Syndrome (disorder)
|
0.510 |
Biomarker
|
disease |
CLINGEN |
Expression of multiple KCNE genes in human heart may enable variable modulation of I(Ks).
|
15698834 |
2005 |
Hyperkalemic periodic paralysis
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
Last, because hyperkalemic PP has been described to be associated with an R83H mutation of a MiRP2 potassium channel subunit, evidence refuting disease-causality in this case will be discussed.
|
17395131 |
2007 |
Hyperkalemic periodic paralysis
|
0.330 |
GeneticVariation
|
disease |
ORPHANET |
Strict bed rest following lumbar puncture in children and adolescents is of no benefit.
|
15037713 |
2004 |
Hyperkalemic periodic paralysis
|
0.330 |
GeneticVariation
|
disease |
ORPHANET |
Lack of association of the potassium channel-associated peptide MiRP2-R83H variant with periodic paralysis.
|
14504341 |
2003 |
Hyperkalemic periodic paralysis
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
Clinical and electrophysiological data have outlined a spectrum of similar yet distinct periodic paralyses, including potassium-sensitive (hyperkalemic periodic paralysis [HYPP]) and temperature-sensitive (paramyotonia congenita [PC]) forms.
|
8388676 |
1993 |
Hyperkalemic periodic paralysis
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
The observation of a distinct mutation that cosegregates with HYPP in two families and appears as a de novo mutation in a third establishes SCN4A as the HYPP gene.
|
1659948 |
1991 |
Long QT Syndrome
|
0.310 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
To investigate the association between KCNE3 and LQTS, we conducted a genetic screening of KCNE3 mutations and single nucleotide polymorphisms (SNPs) in 485 Japanese LQTS probands using DHPLC-WAVE system and direct sequencing.
|
19306396 |
2009 |
Long QT Syndrome
|
0.310 |
Biomarker
|
disease |
BEFREE |
To investigate the association between KCNE3 and LQTS, we conducted a genetic screening of KCNE3 mutations and single nucleotide polymorphisms (SNPs) in 485 Japanese LQTS probands using DHPLC-WAVE system and direct sequencing.
|
19306396 |
2009 |
Hypokalemic periodic paralysis
|
0.310 |
GeneticVariation
|
disease |
ORPHANET |
Strict bed rest following lumbar puncture in children and adolescents is of no benefit.
|
15037713 |
2004 |
Hypokalemic periodic paralysis
|
0.310 |
GeneticVariation
|
disease |
ORPHANET |
Lack of association of the potassium channel-associated peptide MiRP2-R83H variant with periodic paralysis.
|
14504341 |
2003 |
Hypokalemic periodic paralysis
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
A mutation in the KCNE3 potassium channel gene is associated with susceptibility to thyrotoxic hypokalemic periodic paralysis.
|
12414843 |
2002 |
Syncope
|
0.110 |
GeneticVariation
|
phenotype |
BEFREE |
Besides identifying 8 SCN5A mutations in the present cohort, a KCNE3 T4A mutation was found in a 55-year-old male patient who had experienced several episodes of syncope.
|
22987075 |
2012 |
Syncope
|
0.110 |
Biomarker
|
phenotype |
HPO |
|
|
|
Low density lipoprotein cholesterol measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.
|
23063622 |
2012 |
Triglycerides measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.
|
23063622 |
2012 |